Search Results - Zhuang Wu
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
-
2
-
3
-
4
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study by Wang, Wenxian, Wang, Hong, Lu, Peihua, Yu, Zongyang, Xu, Chunwei, Zhuang, Wu, Song, Zhengbo
Published 2019Text -
5
-
6
Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer by Lin, Gen, Li, Chao, Huang, Cheng, Zhuang, Wu, Huang, Yunjian, Xu, Haipeng, Miao, Qian, Hu, Dan
Published 2018Text -
7
-
8
-
9
-
10
-
11
Comparison of Rearranged During Transfection (RET) Gene Rearrangements in Primary Versus Metastatic Non-Small Cell Lung Cancer (NSCLC) by Zhang, Quxia, Xu, Chunwei, Wang, Wenxian, Wu, Meijuan, Zhu, Youcai, Zhuang, Wu, Du, Kaiqi, Huang, Yunjian, Chen, Yanping, Wu, Biao
Published 2018Text -
12
-
13
-
14
Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer by Lin, Gen, Fan, Xirong, Zhu, Weifeng, Huang, Cheng, Zhuang, Wu, Xu, Haipeng, Lin, Xiandong, Hu, Dan, Huang, Yunjian, Jiang, Kan, Miao, Qian, Li, Chao
Published 2017Text -
15
A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib by Zhu, You-cai, Wang, Wen-xian, Xu, Chun-wei, Zhuang, Wu, Song, Zheng-bo, Du, Kai-qi, Chen, Gang, Lv, Tang-feng, Song, Yong
Published 2018Text -
16
Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib by Zhu, You-Cai, Wan, Bing, Wu, Li-Xin, Li, Xing-Liang, Wang, Wen-Xian, Xu, Chun-Wei, Zhuang, Wu, Wei, Jian-Guo, Du, Kai-Qi
Published 2019Text -
17
Genetic mutations in lung enteric adenocarcinoma identified using next-generation sequencing by Lin, Li, Zhuang, Wu, Wang, Wenxian, Xu, Chunwei, Chen, Rongrong, Guan, Yanfang, Yi, Xin, Shao, Yun, Tai, Yanhong, Chen, Yanping, Wu, Meijuan, Wei, Jianguo, Chen, Gang
Published 2017Text -
18
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lu... by Wang, Wenxian, Huang, Zhangzhou, Yu, Zongyang, Zhuang, Wu, Zheng, Weijun, Cai, Zhijian, Shi, Lei, Yu, Xinmin, Lou, Guangyuan, Hong, Wei, Zhang, Yiping, Chen, Ming, Song, Zhengbo
Published 2020Text -
19
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report by Zhu, You-cai, Liao, Xing-hui, Wang, Wen-xian, Xu, Chun-wei, Zhuang, Wu, Zhong, Li-hua, Du, Kai-qi, Chen, Yan-ping, Chen, Gang, Fang, Mei-yu
Published 2017Text -
20
Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospectiv... by Lei, Lei, Wang, Wen-Xian, Zhu, You-Cai, Pu, Xing-Xiang, Fang, Yong, Wang, Hong, Zhuang, Wu, Zhang, Yin-Bin, Wang, Li-Ping, Xu, Chun-Wei, Fang, Mei-Yu
Published 2020Text
Search Tools:
Related Subjects
Medicine
Biology
Immunology
Gene
Internal medicine
Cell biology
Biochemistry
Cancer research
Downregulation and upregulation
Embryonic stem cell
Genetics
Inflammation
Lung
Myosin
Pathology
Stem cell
Actin
Antibody
Antibody-drug conjugate
Basal ganglia
Bone morphogenetic protein
Cancer
Cell
Cellular differentiation
Central nervous system
Cerebellum
Chemistry
Clinical trial
Coagulation
Conjugate